Literature DB >> 4762056

Serum levels of thioridazine in psychiatric patients and healthy volunteers.

E Mårtensson, B E Roos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4762056     DOI： 10.1007/bf00558283

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  13 in total

1.  SERUM CONCENTRATIONS OF THIORIDAZINE AFTER DIFFERENT ORAL MEDICATION FORMS.

Authors:  T J MELLINGER
Journal:  Am J Psychiatry       Date:  1965-05       Impact factor: 18.112

2.  THIORIDAZINE BLOOD LEVELS IN PATIENTS RECEIVING DIFFERENT ORAL FORMS.

Authors:  T J MELLINGER; E M MELLINGER; W T SMITH
Journal:  Clin Pharmacol Ther       Date:  1965 Jul-Aug       Impact factor: 6.875

3.  Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug.

Authors:  S H Curry; G P Mould
Journal:  J Pharm Pharmacol       Date:  1969-10       Impact factor: 3.765

Review 4.  Biochemical and genetic factors regulating dilantin metabolism in man.

Authors:  H Kutt
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

5.  Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.

Authors:  A Redfors
Journal:  Br Heart J       Date:  1972-04

6.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

7.  Pharmacological and clinical problems of lithium prophylaxis.

Authors:  M Schou; P C Baastrup; P Grof; P Weis; J Angst
Journal:  Br J Psychiatry       Date:  1970-06       Impact factor: 9.319

8.  Plasma protein binding, plasma concentrations, and effects of diphenylhydantoin in man.

Authors:  L Lund; P K Lunde; A Rane; O Borga; F Sjöqvist
Journal:  Ann N Y Acad Sci       Date:  1971-07-06       Impact factor: 5.691

9.  Relationship between plasma level and therapeutic effect of nortriptyline.

Authors:  M Asberg; B Crönholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1971-08-07

10.  Effect of age and sex on human drug metabolism.

Authors:  K O'Malley; J Crooks; E Duke; I H Stevenson
Journal:  Br Med J       Date:  1971-09-11
View more
  12 in total

1.  Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.

Authors:  P Arlock; B Gullberg; S R Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

Review 2.  Plasma level monitoring of antipsychotic drugs.

Authors:  T B Cooper
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

3.  Pharmacokinetics and relative bioavailability of levomepromazine after repeated administration of tablets and syrup.

Authors:  S G Dahl; R E Strandjord; S Sigfusson
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

4.  Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

5.  Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.

Authors:  F A Vanderheeren; R G Muusze
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

6.  Single-dose kinetics of the neuroleptic drug perazine in psychotic patients.

Authors:  U Breyer-Pfaff; K Nill; H W Schied; H J Gaertner; H Giedke
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

7.  Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.

Authors:  R G Muusze; F A Vanderheeren
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

8.  Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.

Authors:  A Carlsson; B E Roos; J Wålinder; A Skott
Journal:  J Neural Transm       Date:  1973       Impact factor: 3.575

9.  Clinical pharmacokinetic studies of perphenazine.

Authors:  C Eggert Hansen; T Rosted Christensen; J Elley; L Bolvig Hansen; P Kragh-Sorensen; N E Larsen; J Naestoft; E F Hvidberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

10.  Effect of thioridazine on experimental cutaneous staphylococcal infections.

Authors:  Beth L Hahn; Peter G Sohnle
Journal:  In Vivo       Date:  2014 Jan-Feb       Impact factor: 2.155
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.